Kidney stone analysis may miss diagnoses as demonstrated by a case of adenine phosphoribosyl transferase deficiency.
No Thumbnail Available
All Authors
Bramley, R.
Herrera, D.
Barski, R.
Henderson, M.
LTHT Author
Barski, Robert
Henderson, Michael
Henderson, Michael
LTHT Department
Pathology
Specialist Laboratory Medicine
Specialist Laboratory Medicine
Non Medic
Clinical Scientist
Clinical Scientist
Clinical Scientist
Publication Date
2025
Item Type
Journal Article
Language
Subject
Subject Headings
Abstract
Fourier-transformed infrared (FTIR) spectroscopy is a frequently requested test in patients with kidney stones. It is considered particularly useful when routine stone urine screens do not identify any significant abnormalities. This case report describes a patient with undiagnosed adenine phosphoribosyltransferase (APRT) deficiency, a disorder presenting with kidney stones, who had initial symptoms at 16 months of age but no diagnosis until they were 6 years old. Initial investigations including a urine stone screen did not show significant abnormalities; however, FTIR analysis suggested the stones had a significant component identified as lansoprazole, a drug the patient was not taking. After repeated stone formation, urinary tract infections and inpatient stays, the disorder was identified incidentally during validation of a method for purine and pyrimidines in urine. This case highlights that FTIR analysis, although useful, has pitfalls and that other investigations are of equal value in reaching a diagnosis.
Journal
Annals of Clinical Biochemistry